Will new Wegovy data persuade payers to cover the drug?

The latest stories trending on MedCity News.

Editor's Pick

Top Story Novo Nordisk's Wegovy Posts Trial Data Supporting the Drug as Way to Lower Heart Risks Novo Nordisk weight-loss drug Wegovy reduced the risk of major cardiovascular events by 20% in a large clinical trial. The company said the results support expanding the drug's label, but the looming question is whether the data will persuade payers to cover the pricey chronic therapy. Sponsored Content Driving for Results: 3 Key Benefits of Telehealth Presented by Greenway Health Explore the myriad benefits telehealth offers to healthcare providers and patients alike. From enhanced convenience and improved privacy to streamlined workflows and elevated patient satisfaction, find out how telehealth is reshaping the future of healthcare delivery. Learn More>> Fireside Chat at INVEST Digital Health Don't miss this exciting and exclusive opportunity with Beth Andrews, Chief Digital Health Officer, Life Sciences & Healthcare, Dell Technologies | Global Alliances. She will be discussing how to support the evolution of advanced research, therapy development, and patient care with data. Join us on October 26th at Pegasus Park in Dallas. Hurry, you can still save $150 until 8/25. Register Now

Featured News

Nektar Sues Eli Lilly, Claiming the Big Pharma Breached Contract to Favor Another Drug "Botched math" in calculating clinical data for an autoimmune disease drug is one of the allegations Nektar Therapeutics makes in a legal complaint against Eli Lilly. The biotech claims its former partner tried to disadvantage the asset in order to advance development of another drug it acquired in a billion dollar deal. HHS Warns Providers About a New Cybercriminal Gang Attacking the Healthcare Sector HHS issued an alert warning providers about Rhysida, a ransomware gang that recently begun launching attacks on healthcare organizations. The group deploys its ransomware primarily through phishing attacks or the exploitation of legitimate cybersecurity tools. Report: Black, Latino, Asian Americans Are More Likely To Choose MA Plans Over Traditional About 27% of Medicare Advantage enrollees are Black, Latino or Asian, versus 17% of traditional Medicare enrollees, according to a report conducted by ATI Advisory and commissioned by the Better Medicare Alliance. Daybreak Health Snags $13M For School-Based Mental Health Services Daybreak Health — a startup that partners with school districts to provide children with virtual mental health services — recently closed a $13 million Series B funding round. The company has partnered with more than 60 public school districts since it began providing care in 2019. Scripta Insights Partners with Mark Cuban Cost Plus Drug Company Through Scripta Insights' app, members of its customers can input the medications they're taking, and the company will provide a savings report that will show different options on how they can save on their prescriptions. Starting in 2024, Cost Plus Drugs may show up as an option in the savings report.

Resources

MedCity Moves Podcast: Recent Hires, Layoffs & an Interview with Leslie Orne, CEO of Trinity Life Sciences In this podcast we are joined by Leslie Orne, who just became the new CEO of Trinity Life Sciences. Her company provides consulting services and technology solutions to life sciences firms looking to commercialize their product.  Learn what Orne thinks is in store for AI innovation in the life sciences space. Listen Now

MedCity News • PO Box 901 • New York, NY unsubscribe